Tempus UGT1A1
Single-gene germline pharmacogenomic test for UGT1A1-associated anticancer-therapy toxicity risk.
- Developer
- Tempus AI
- Intended use
- Other
- Cancer scope
- Hematologic neoplasms, Solid tumors
- Specimen
- Saliva, Whole blood
- Molecular modality
- DNA mutation
- Current version
- Current Tempus/OneOme UGT1A1 single-gene PGx test (2026-09)
- Evidence context
- 0 structured studies · 0 indexed performance results · 1 sources
Why can reported performance numbers differ? MDI keeps each result attached to its study, population, stage or stratum, test version and source rather than treating performance as a fixed property of the test.